Navigation Links
Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
Date:9/5/2012

SAN DIEGO, Sept. 5, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced an update to the projected timeframe for enrollment of patients in the Light Study, the cardiovascular outcomes clinical trial evaluating Contrave® (naltrexone SR/ bupropion SR).  Enrollment into the study has continued without abatement at a rate faster than originally expected, with more than 4,500 patients enrolled as of August 31.  Orexigen now expects to close enrollment to new patients in the fourth quarter of 2012.

The primary endpoint of the Light Study is the time to occurrence of major adverse cardiovascular events (MACE) during randomized treatment for Contrave compared to placebo. After at least 87 MACE have been adjudicated, the study's independent Data Monitoring Committee will conduct an interim analysis. If the interim analysis excludes a doubling of risk of MACE in patients receiving Contrave compared to placebo, Orexigen plans to resubmit the Contrave New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for approval. The exclusion of a doubling of risk of MACE was established as the threshold for approvability of Contrave during discussions with the FDA prior to the start of the Light Study.

"By successfully expediting patient enrollment into the Light Study, we are executing on our promise to shareholders to do what we can to pull forward the time to the interim analysis," said Michael Narachi, CEO of Orexigen.

"The other key information needed to determine the timing of the interim analysis is the rate of MACE in the study, which is still too early to know," Narachi continued.  "Importantly, because the demographics of the patient population entering the study are in line with our targets for age, gender, race, smoking status, prevalence of cardiovascular disease and other co-morbid
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
2. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
3. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
6. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
7. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
8. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
9. Echo Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference
10. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) today announced ... Officer and Executive Vice President. Mr. Singh died suddenly and ... "Sorrento is deeply saddened and shocked by the loss of ... Amar,s family and friends," said Henry Ji , Ph.D., ... Singh joined Sorrento in January 2014 from Synta Pharmaceuticals, where ...
(Date:7/31/2014)... 2014 IRIDEX Corporation (Nasdaq: IRIX ) ... months ended June 28, 2014.  , Revenues were ... from $9.2 million in the 2013 second quarter and up ... Revenues for the first six months of 2014 were $20.9 ... months of last year. , Gross margin for the ...
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... Insulin Pump, today reported its financial results for the quarter ... second quarter of 2014 to the same period of 2013: ... $5.5 million , t:slim Pump shipments grew 64 percent ... six months ended June 30, 2014 to the same period ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6
... WASHINGTON, Sept. 15 A home medical equipment provider ... "competitive" bidding program for durable medical equipment and services. ... and wound care specialist at Allcare Medical, in Sayreville, ... on Health that the bidding program, as designed by ...
... Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and... -- MINNEAPOLIS, Minnesota, September 15, ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 2Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 3Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 4Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 5Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 6Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 7Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 2Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 3Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 4Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 5Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 6Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 7Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 8
(Date:8/1/2014)... August 01, 2014 A new study ... that carbohydrates may contribute to the development of colorectal ... the disease. The study was authored by Alberto Martin ... found to cause intestinal cells to multiply and create ... colorectal cancer. , “What’s interesting about this study,” ...
(Date:8/1/2014)... August 01, 2014 This week marks ... completes its 500th week of paying commissions to its ... was founded in January 2005 total $1,405,954,677.06. , MonaVie ... world. The company pays commissions in 18 different currencies, ... MYR, MXN, NZD, PLN, USD, SGD, KRW, TWD, THB ...
(Date:8/1/2014)... A leading dress supplier, Discount-Dress.com, explores a variety of ... any lady’s wardrobe fashionable and exciting. Recently, the company has ... To attract more people, it is now launching a special ... to 65% off. , “Summer is the season of short ... to our collection of ‘ 2014 summer short styles .’ ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... CentraComm, a leading managed IT security ... the Pure Storage® Authorized Reseller program. , ... experience designed to meet the rigorous resiliency, scalability, ... diverse markets, and for a variety of high ... years. , The Pure Storage FlashArray was ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2Health News:Discount-Dress.com’s Top Trend Report: 2014 Summer Short Bridesmaid Dresses Now for Sale 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 3
... Royer Animal Health, LLC, a wholly owned subsidiary ... agreement with MWI Veterinary, Supply, Inc. (Nasdaq: ... MATRIX III CISPLATIN BEADS and R-GEL ... products provide veterinary professionals with localized treatment options for ...
... of many public services to head off infections , , ... swine flu cases in the United States has surpassed 100, ... to be the source of the outbreak -- braced for ... limit further infections in that country, where the virus is ...
... flu topping the agenda of,business around the world, global ... revealing the countries most at risk from an,influenza pandemic. ... Index (IPRI) consists of three categories:,Risk of Emergence, Risk ... list of countries most at risk and that require ...
... April 30 The Providence Service Corporation (Nasdaq: ... to report financial results for its first quarter ended March ... closes.Providence will hold a conference call at 11:00 a.m. EDT ... May 7, 2009, to discuss its financial results and corporate ...
... the world exercise in unison for 21st annual Project ACES ... the globe will walk, jog, bike or play games on ... (All Children Exercise Simultaneously) Day. This Youth Fitness ... College of Sports Medicine ,s Exercise is ...
... PREPARES FOR LAUNCH OF ,NEST-3, ACUTE ISCHEMIC STROKE CLINICAL ... of transcranial laser therapy (TLT) designed for the treatment ... onset, announced today that it has closed a $50 ... Pincus, a leading global private equity firm, to fund ...
Cached Medicine News:Health News:Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections 2Health News:Swine Flu Infections Surpass 100 in U.S. 2Health News:Swine Flu Infections Surpass 100 in U.S. 3Health News:Swine Flu Infections Surpass 100 in U.S. 4Health News:Swine Flu Infections Surpass 100 in U.S. 5Health News:Swine Flu Infections Surpass 100 in U.S. 6Health News:Maplecroft Flu Pandemic Maps Reveal Countries Most at Risk 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 3Health News:Youth to Fight Obesity With World's Largest Exercise Class 2Health News:Youth to Fight Obesity With World's Largest Exercise Class 3Health News:PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer 2Health News:PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer 3
The Active Ankle Trainer model provides medial/lateral support and optimum ankle mobility for chronic and prophylactic use....
... The Bledsoe PTB Boot is ... alternative to casting for the mid-tibia ... providing patella tendon bearing support. The ... designed for range of motion from ...
... The Bledsoe Hi-Top Boot is designed ... casting for the mid-tibia or fibula to ... third degree ankle sprains. The Bledsoe EZ ... of motion from 20 degrees of dorsi-flexion ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: